Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Friday September 25, 2009

DrStockPick.com Stock Report!

**************************************************************

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced the pricing of a public offering of 3 million shares of its common stock. The offering is expected to close on or about September 30, 2009, subject to customary closing conditions. In addition, Auxilium has granted the underwriter a 30-day option to purchase up to an additional 450,000 shares to cover over-allotments, if any.

Affymax, Inc. (Nasdaq:AFFY) today announced that it has obtained an issuer managed

...

DrStockPick.com Stock Report!

Thursday August 27, 2009

**************************************************************

Oriental Financial Group Inc. (NYSE: OFG) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.04 per common share for the third quarter ending September 30, 2009, payable on October 15, 2009, to holders of record on September 30, 2009, with an ex-dividend date of September 28, 2009.

Xerox Corporation (NYSE: XRX) has been positioned by Gartner, Inc., in the Leaders Quadrant of the 2009 Magic Quadrant for Managed Print Services (MPS) Worldwide

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in the Thomas Weisel Partners Healthcare Conference to be held September 9 - 11,

...

DrStockPick.com Stock Report!

Friday July 31, 2009

**************************************************************

Kaydon Corporation (NYSE:KDN) today announced that its Board of Directors declared a 5.9 percent increase in its regular quarterly dividend, to $.18 per share from $.17 per share. The dividend is payable on October 5, 2009 to shareholders of record as of the close of business on September 14, 2009. The indicated annual dividend rate will now be $.72 per share. This is the third consecutive year in which the Company has increased its quarterly dividend.

SPAR Group, Inc. (Nasdaq:SGRP) today reported financial results for the second quarter and six months ended June 30, 2009. Net revenues for the 2009 second quarter were $13.5 million, compared

...

For Immediate Release

Chicago, IL - May 8, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Auxilium Pharmaceuticals, Inc. (AUXL), Pfizer (PFE), Cognizant Technology Solutions Corp. (CTSH), Neurocrine Biosciences, Inc. (NBIX) and Coca-Cola FEMSA S.A. de C.V. (KOF).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Thursday's Analyst Blog:

Auxilium a Buy at $20

Auxilium Pharmaceuticals, Inc. (AUXL) reported financial results for the first quarter 2009 on May 6, 2009. Total revenues for the first quarter were $34.7 million, an increase of 28% over the first quarter

...

Auxilium Pharmaceuticals, Inc. (AUXL) reported financial results for the first quarter 2009 on May 6, 2009. Total revenues for the first quarter were $34.7 million, an increase of 28% over the first quarter in 2008.Revenues consisted of approximately $32.5 million in U.S. sales of Testim, up 20% year-over-year, $1.3 million in milestone recognition from Ferring International S.A. on ex-U.S. Testim activities, and $0.9 million in amortization from the previous upfront payment from Pfizer (PFE). This was slightly lower than expected by about $2.0 million based on lower sales of Testim.Management noted that managed-care changes and inventory de-stocking negatively impacted sales. Also, the difficult economic environment had a negative impact on Testim sales during the first quarter. Net loss for the first quarter totaled $13.2 million, or $0.31 per share. This was a slightly greater loss than expected based on lower sales of Testim ...